KHAYAL TAMER I (Chief Commercial Officer) sold 6.3% of their position (2.41K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $184.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2025ACC: 0000950170-25-033706
Officer· Chief Commercial Officer
Since May 2019
-2.41K
Net shares
Net seller
$184.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.41K
Price / share
$76.43
Trade value
$183.97K
% of position
6.3%
3/3/2025
38.45K→36.04K
Total
Net shares
−2.41K
Net value
-$183.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2025 | S · Sale | −2.41K | $76.43 | $183.97K | 6.3% | 38.45K | 36.04K |
| Total | −2.41K | -$183.97K | ||||||
Derivative Transactions0
No derivative transactions reported